Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)

Oct. 7, 2022, 9:15 PM UTC

Teva Pharmaceutical Industries Ltd.will continue to have challenges supplying the popular attention-deficit/hyperactivity disorder drug Adderall for the next two to three months, a company spokesperson said.

The drug has been in short supply since at least August, an issue that started this summer with a labor shortage at Teva, which supplies more Adderall in the US than any other company. Teva sells both the branded and generic products, and demand for the drug is at an all-time high.

Teva spokesperson Kelley Dougherty said the company continues to experience intermittent delays in Adderall production and is “producing and distributing ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.